Dina Xie

574 total citations
16 papers, 379 citations indexed

About

Dina Xie is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Dina Xie has authored 16 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Dina Xie's work include Extracellular vesicles in disease (4 papers), Cardiovascular Disease and Adiposity (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Dina Xie is often cited by papers focused on Extracellular vesicles in disease (4 papers), Cardiovascular Disease and Adiposity (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Dina Xie collaborates with scholars based in United States, China and Hong Kong. Dina Xie's co-authors include Xinliang Ma, Wayne Bond Lau, Theodore A. Christopher, Lu Gan, Erhe Gao, Bernard S. López, Walter J. Koch, Jing Liu, Yajing Wang and Ling Zhang and has published in prestigious journals such as Circulation, Circulation Research and Scientific Reports.

In The Last Decade

Dina Xie

16 papers receiving 377 citations

Peers

Dina Xie
Na Zhou China
Xiaosheng Hu China
Ji‐Peng Zhou China
Jiahe Xie China
Lucas Bacmeister Germany
Jingmin Zhou China
Qicai Wu China
Ruiqin Xie China
Kar Sheng Lew New Zealand
Na Zhou China
Dina Xie
Citations per year, relative to Dina Xie Dina Xie (= 1×) peers Na Zhou

Countries citing papers authored by Dina Xie

Since Specialization
Citations

This map shows the geographic impact of Dina Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Xie more than expected).

Fields of papers citing papers by Dina Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Xie. The network helps show where Dina Xie may publish in the future.

Co-authorship network of co-authors of Dina Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Xie. A scholar is included among the top collaborators of Dina Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Xie. Dina Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Shuangya, Keying Liu, Dina Xie, et al.. (2024). Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy. Signal Transduction and Targeted Therapy. 9(1). 272–272. 21 indexed citations
2.
3.
Xie, Dina, Hanliang Guo, Liqun Jia, et al.. (2023). Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion. Basic Research in Cardiology. 118(1). 44–44. 18 indexed citations
4.
Zhao, Jianli, Zhen Zhang, John H. Zhang, et al.. (2023). Dysfunctional APPL1-Mediated Epigenetic Regulation in Diabetic Vascular Injury. Arteriosclerosis Thrombosis and Vascular Biology. 43(12). e491–e508. 4 indexed citations
5.
Yan, Zheyi, Chunfang Wang, Zhijun Meng, et al.. (2022). C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood–Retinal Barrier Tight Junctions. Cells. 11(5). 779–779. 19 indexed citations
6.
Zhu, Di, Zhen Zhang, Jianli Zhao, et al.. (2022). Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure. Circulation Research. 131(2). e34–e50. 19 indexed citations
7.
Xie, Dina, et al.. (2021). The Protective Effect of Traditional Chinese Medicine on Liver Ischemia-Reperfusion Injury. Evidence-based Complementary and Alternative Medicine. 2021. 1–5. 8 indexed citations
8.
Gan, Lu, Demin Liu, Dina Xie, et al.. (2021). Ischemic Heart-Derived Small Extracellular Vesicles Impair Adipocyte Function. Circulation Research. 130(1). 48–66. 46 indexed citations
9.
10.
Liu, Demin, et al.. (2021). SD + SV4 diagnosis of left ventricular hypertrophy, a revaluation of ECG criterion by cardiac magnetic resonance imaging. Annals of Noninvasive Electrocardiology. 26(4). e12832–e12832. 1 indexed citations
11.
Liu, Jing, Zhijun Meng, Lu Gan, et al.. (2020). C1q/TNF-related protein 5 contributes to diabetic vascular endothelium dysfunction through promoting Nox-1 signaling. Redox Biology. 34. 101476–101476. 24 indexed citations
12.
Xie, Dina, Jianli Zhao, Rui Guo, et al.. (2020). Sevoflurane Pre-conditioning Ameliorates Diabetic Myocardial Ischemia/Reperfusion Injury Via Differential Regulation of p38 and ERK. Scientific Reports. 10(1). 23–23. 25 indexed citations
13.
14.
Guo, Rui, Lu Gan, Wayne Bond Lau, et al.. (2019). Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling. Circulation Journal. 83(8). 1726–1736. 25 indexed citations
15.
Gan, Lu, Dina Xie, Wayne Bond Lau, et al.. (2019). Abstract 646: Myocardial Ischemia/Reperfusion Impairs Adipocyte Endocrine Function via Exosome-Mediated Endoplasmic Reticulum Dysfunction. Circulation Research. 125(Suppl_1). 1 indexed citations
16.
Zheng, Yanjie, Dina Xie, Ching‐Shwun Lin, et al.. (2011). 933 AMNIOTIC FLUID-DERIVED MESENCHYMAL STEM CELLS AS A NOVEL THERAPEUTIC APPROACH IN THE TREATMENT OF FULMINANT HEPATIC FAILURE IN RATS. Journal of Hepatology. 54. S373–S373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Zhou Breakdown of academic impact, for papers by Xiaosheng Hu Breakdown of academic impact, for papers by Ji‐Peng Zhou Breakdown of academic impact, for papers by Jiahe Xie Breakdown of academic impact, for papers by Lucas Bacmeister Breakdown of academic impact, for papers by Jingmin Zhou Breakdown of academic impact, for papers by Qicai Wu Breakdown of academic impact, for papers by Ruiqin Xie Breakdown of academic impact, for papers by Kar Sheng Lew
Rankless by CCL
2026